Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Surgical Oncology ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Ultra-rare sarcomas: a consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities.Cancer. 2021; 127: 2934-2942
- Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network.PLoS One. 2021; 16: e0246958
- Clinical patterns and outcome in epithelioid hemangioendothelioma with or without pulmonary involvement: insights from an internet registry in the study of a rare cancer.Chest. 2011; 140: 1312-1318
- Prognostic stratification of clinical and molecular epithelioid hemangioendothelioma subsets.Mod Pathol. 2020; 33: 591-602
- Malignant vascular tumors--an update.Mod Pathol. 2014; 27: S30-S38
- Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts.ESMO Open. 2021; 6: 100170
- Clinical characteristics of Japanese patients with epithelioid hemangioendothelioma: a multicenter retrospective study.BMC Cancer. 2018; 18: 993
- Clinical prognostic factors in advanced epithelioid haemangioendothelioma: a retrospective case series analysis within the Italian Rare Cancers Network.ESMO Open. 2021; 6: 100083
- Utility of the immunohistochemical detection of FLI-1 expression in round cell and vascular neoplasm using a monoclonal antibody.Mod Pathol. 2004; 17: 547-552
- Primary vascular tumors of bone: a monoinstitutional morphologic and molecular analysis of 427 cases with emphasis on epithelioid variants.Am J Surg Pathol. 2020; 44: 1192-1203
- A novel WWTR1-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites.Genes Chromosomes Cancer. 2011; 50: 644-653
- Variant WWTR1 gene fusions in epithelioid hemangioendothelioma-a genetic subset associated with cardiac involvement.Genes Chromosomes Cancer. 2020; 59: 389-395
- Pulmonary epithelioid haemangioendothelioma in 21 patients, including three with partial spontaneous regression.Eur Respir J. 1998; 12: 89-96
- Spontaneous complete regression of hepatic epithelioid haemangioendothelioma.Lancet Oncol. 2006; 7: 439-441
- Clinicopathologic characterization of epithelioid hemangioendothelioma in a series of 62 cases: a proposal of risk stratification and identification of a synaptophysin-positive aggressive subset.Am J Surg Pathol. 2021; 45: 616-626
- Prognostic factors and surgical indications of pulmonary epithelioid hemangioendothelioma: a review of the literature.Ann Thorac Surg. 2006; 82: 2010-2013
- Imaging findings in epithelioid hemangioendothelioma.Clin Imaging. 2019; 58: 59-65
- Epithelioid hemangioendothelioma: an overview and update on a rare vascular tumor.Oncol Rev. 2014; 8: 259
- The role of local therapy in multi-focal epithelioid haemangioendothelioma.Anticancer Res. 2019; 39: 4891-4896
- Systemic treatment options for epithelioid haemangioendothelioma: the Royal Marsden Hospital experience.Anticancer Res. 2015; 35: 473-480
- Systemic therapies in advanced epithelioid haemangioendothelioma: a retrospective international case series from the World Sarcoma Network and a review of literature.Cancer Med. 2021; 10: 2645-2659
- Response of epithelioid haemangioendothelioma to liposomal doxorubicin.Lancet Oncol. 2005; 6: 813-815
- Malignant epithelioid hemangioendothelioma of the liver successfully treated with pegylated liposomal doxorubicin.J Clin Oncol. 2011; 29: e722-e724
- An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas.Ann Oncol. 2013; 24: 257-263
- Sorafenib in patients with progressive epithelioid hemangioendothelioma: a phase 2 study by the French Sarcoma Group (GSF/GETO).Cancer. 2013; 119: 2639-2644
- Pazopanib for metastatic pulmonary epithelioid hemangioendothelioma-a suitable treatment option: case report and review of anti-angiogenic treatment options.BMC Cancer. 2015; 15: 402
- Pazopanib in advanced vascular sarcomas: an EORTC Soft Tissue and Bone Sarcoma Group (STBSG) retrospective analysis.Acta Oncol. 2017; 56: 88-92
- Sirolimus in advanced epithelioid hemangioendothelioma: a retrospective case-series analysis from the Italian Rare Cancer Network database.Ann Surg Oncol. 2016; 23: 2735-2744
- P10015/SARC033: a phase 2 trial of trametinib in patients with advanced epithelioid hemangioendothelioma (EHE).J Clin Oncol. 2021; 39: 11503
- Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS clinical practice guidelines for diagnosis, treatment and follow-up∗.Ann Oncol. 2021; 32: 1348-1365
- Team-based outpatient early palliative care: a complex cancer intervention.BMJ Support Palliat Care. 2019; https://doi.org/10.1136/bmjspcare-2019-001903
- Kaposiform hemangioendothelioma: atypical features and risks of Kasabach-Merritt phenomenon in 107 referrals.J Pediatr. 2013; 162: 142-147
- Kaposiform haemangioendothelioma: clinical features, complications and risk factors for Kasabach-Merritt phenomenon.Br J Dermatol. 2018; 179: 457-463
- Capillary hemangioma with extensive purpura: report of a case.Am J Dis Child. 1940; 59: 1063-1070
- Kaposiform hemangioendothelioma: a study of 33 cases emphasizing its pathologic, immunophenotypic, and biologic uniqueness from juvenile hemangioma.Am J Surg Pathol. 2004; 28: 559-568
- Consensus-derived practice standards plan for complicated Kaposiform hemangioendothelioma.J Pediatr. 2013; 163: 285-291
- Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: a multicenter retrospective study.Int J Cancer. 2017; 141: 848-855
- Pseudomyogenic hemangioendothelioma: a distinctive, often multicentric tumor with indolent behavior.Am J Surg Pathol. 2011; 35: 190-201
- Translocation t(7;19)(q22;q13)-a recurrent chromosome aberration in pseudomyogenic hemangioendothelioma?.Cancer Genet. 2011; 204: 211-215
- Expanding the spectrum of genetic alterations in pseudomyogenic hemangioendothelioma with recurrent novel ACTB-FOSB gene fusions.Am J Surg Pathol. 2018; 42: 1653-1661
- A novel CLTC-FOSB gene fusion in pseudomyogenic hemangioendothelioma of bone.Genes Chromosomes Cancer. 2021; 60: 38-42
- Novel EGFL7-FOSB fusion in pseudomyogenic haemangioendothelioma with widely metastatic disease.Histopathology. 2021; 79: 888-891
- Pseudomyogenic hemangioendothelioma of bone with rare WWTR1-FOSB fusion gene: case report and literature review.Clin Case Rep. 2021; 9: 1494-1499
- Diagnostic utility of FOSB immunohistochemistry in pseudomyogenic hemangioendothelioma and its histological mimics.Diagn Pathol. 2016; 11: 75
- FOSB is a useful diagnostic marker for pseudomyogenic hemangioendothelioma.Am J Surg Pathol. 2017; 41: 596-606
- Cytotoxic and targeted therapy for treatment of pseudomyogenic hemangioendothelioma.Clin Sarcoma Res. 2015; 5: 22
- Everolimus for treatment of pseudomyogenic hemangioendothelioma.J Pediatr Hematol Oncol. 2017; 39: e328-e331
- Telatinib is an effective targeted therapy for pseudomyogenic hemangioendothelioma.Clin Cancer Res. 2018; 24: 2678-2687
- Retiform hemangioendothelioma. A distinctive form of low-grade angiosarcoma delineated in a series of 15 cases.Am J Surg Pathol. 1994; 18: 115-125
- Vascular tumours in infants. Part II: vascular tumours of intermediate malignancy [corrected] and malignant tumours.Br J Dermatol. 2014; 171: 474-484
- Unresectable retiform hemangioendothelioma treated with external beam radiation therapy and chemotherapy: a case report and review of the literature.Sarcoma. 2010; 2010https://doi.org/10.1155/2010/75624690
- Composite hemangioendothelioma: a complex, low-grade vascular lesion mimicking angiosarcoma.Am J Surg Pathol. 2000; 24: 352-361
- Composite hemangioendothelioma: clinical and histologic features of an enigmatic entity.Adv Anat Pathol. 2015; 22: 254-259
- Composite hemangioendothelioma with neuroendocrine marker expression: an aggressive variant.Mod Pathol. 2017; 30: 1512
- Recurrent YAP1 and MAML2 gene rearrangements in retiform and composite hemangioendothelioma.Am J Surg Pathol. 2020; 44: 1677-1684
- Pathologic angiogenesis of malignant vascular sarcomas: implications for treatment.J Clin Oncol. 2018; 36: 194-201
- Cellular injury and cell proliferation in skin carcinogenesis by UV light.Oncology. 1975; 31: 61-75
- The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research.Nat Med. 2020; 26: 181-187
- Increased risk of soft tissue sarcoma after radiotherapy in women with breast carcinoma.Cancer. 2001; 92: 172-180
- Stewart Treves syndrome.An Bras Dermatol. 2015; 90: 229-231
- Liver damage and angiosarcoma in vinyl chloride workers. A systematic detection program.JAMA. 1974; 230: 64-68
- Pathology related to chronic arsenic exposure.Environ Health Perspect. 2002; 110: 883-886
- Hepatic angiosarcoma associated with androgenic-anabolic steroids.Lancet. 1979; 2: 1249
- Angiosarcoma with malignant peripheral nerve sheath tumour developing in a patient with Klippel-Trenaunay-Weber syndrome.Sarcoma. 2005; 9: 137-140
- A mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li-Fraumeni-like families.Nat Commun. 2015; 6: 8383
- Cutaneous angiosarcoma: a current update.J Clin Pathol. 2017; 70: 917-925
- Vascular sarcomas.Curr Oncol Rep. 2013; 15: 347-355
- Angiosarcoma.Lancet Oncol. 2010; 11: 983-991
- Cutaneous malignant vascular neoplasms.Clin Lab Med. 2017; 37: 633-646
- Secondary sarcomas after radiotherapy for breast cancer: sustained risk and poor survival.Cancer. 2009; 115: 4055-4063
- Primary hepatic angiosarcoma.Eur J Surg Oncol. 2015; 41: 1137-1143
- Cardiac angiosarcoma management and outcomes: 20-year single-institution experience.Ann Surg Oncol. 2012; 19: 2707-2715
- Clinical characteristics and prognostic factors of primary splenic angiosarcoma: a retrospective clinical analysis from China.Cell Physiol Biochem. 2018; 49: 1959-1969
- Angiosarcoma of soft tissue: a study of 80 cases.Am J Surg Pathol. 1998; 22: 683-697
- Distinct histological features characterize primary angiosarcoma of bone.Histopathology. 2011; 58: 254-264
- Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens--evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor.Mod Pathol. 1994; 7: 82-90
- The utility of ERG, CD31 and CD34 in the cytological diagnosis of angiosarcoma: an analysis of 25 cases.J Clin Pathol. 2015; 68: 44-50
- Recurrent PTPRB and PLCG1 mutations in angiosarcoma.Nat Genet. 2014; 46: 376-379
- Alterations of the p53 and PIK3CA/AKT/mTOR pathways in angiosarcomas: a pattern distinct from other sarcomas with complex genomics.Cancer. 2012; 118: 5878-5887
- Mutations of p53 tumor-suppressor gene in angiosarcoma.Int J Cancer. 1997; 71: 952-955
- Targeted massively parallel sequencing of angiosarcomas reveals frequent activation of the mitogen activated protein kinase pathway.Oncotarget. 2015; 6: 36041-36052
- Recurrent CIC gene abnormalities in angiosarcomas: a molecular study of 120 cases with concurrent investigation of PLCG1, KDR, MYC, and FLT4 gene alterations.Am J Surg Pathol. 2016; 40: 645-655
- FISH for MYC amplification and anti-MYC immunohistochemistry: useful diagnostic tools in the assessment of secondary angiosarcoma and atypical vascular proliferations.J Cutan Pathol. 2012; 39: 234-242
- MYC high level gene amplification is a distinctive feature of angiosarcomas after irradiation or chronic lymphedema.Am J Pathol. 2010; 176: 34-39
- Postradiation cutaneous angiosarcoma after treatment of breast carcinoma is characterized by MYC amplification in contrast to atypical vascular lesions after radiotherapy and control cases: clinicopathological, immunohistochemical and molecular analysis of 66 cases.Mod Pathol. 2012; 25: 75-85
- MYC amplification and overexpression in primary cutaneous angiosarcoma: a fluorescence in-situ hybridization and immunohistochemical study.Mod Pathol. 2014; 27: 509-515
- Immunohistochemical and fluorescence in situ hybridization analysis of MYC in a series of 17 cutaneous angiosarcomas: a single-center study.Am J Dermatopathol. 2018; 40: 349-354
- High terminal hemorrhage risk from cardiac angiosarcoma brain metastases warrants frequent brain imaging and early intervention.Int J Radiat Oncol Biol Phys. 2021; 111: e314
- Angiosarcoma. A report of 67 patients and a review of the literature.Cancer. 1996; 77: 2400-2406
- Optimal clinical management and the molecular biology of angiosarcomas.Cancers (Basel). 2020; 12https://doi.org/10.3390/cancers1211332191
- Evaluation of the use and efficacy of (neo)adjuvant chemotherapy in angiosarcoma: a multicentre study.ESMO Open. 2020; 5https://doi.org/10.1136/esmoopen-2020-000787105
- A phase II study of oraxol in the treatment of unresectable cutaneous angiosarcoma.J Clin Oncol. 2020; 38: 11517
- Outcomes after definitive treatment for cutaneous angiosarcoma of the face and scalp.Head Neck. 2011; 33: 661-667
- Cutaneous angiosarcoma of the scalp: a multidisciplinary approach.Cancer. 2003; 98: 1716-1726
- First-line anthracycline-based chemotherapy for angiosarcoma and other soft tissue sarcoma subtypes: pooled analysis of eleven European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group trials.Eur J Cancer. 2014; 50: 3178-3186
- Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomas.Cancer. 2012; 118: 3330-3336
- A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy.Cancer J. 2005; 11: 241-247
- Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study.J Clin Oncol. 2008; 26: 5269-5274
- Paclitaxel given once per week with or without bevacizumab in patients with advanced angiosarcoma: a randomized phase II trial.J Clin Oncol. 2015; 33: 2797-2802
- Gemcitabine in advanced angiosarcoma: a retrospective case series analysis from the Italian Rare Cancer Network.Ann Oncol. 2012; 23: 501-508
- Sorafenib for patients with advanced angiosarcoma: a phase II trial from the French Sarcoma Group (GSF/GETO).Oncologist. 2012; 17: 260-266
- Phase II study of sorafenib in patients with metastatic or recurrent sarcomas.J Clin Oncol. 2009; 27: 3133-3140
- Results of the TAPPAS trial: an adaptive enrichment phase III trial of TRC105 and pazopanib (P) versus pazopanib alone in patients with advanced angiosarcoma (AS).Ann Oncol. 2019; 30: v683
- Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours.Eur J Cancer. 2019; 120: 132-139
- Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART).J Immunother Cancer. 2021; 9https://doi.org/10.1136/jitc-2021-002990109
- Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institution.J Immunother Cancer. 2019; 7: 213
- Cutaneous angiosarcoma. Analysis of 434 cases from the Surveillance, Epidemiology, and End Results Program, 1973-2007.Ann Diagn Pathol. 2011; 15: 93-97
- Predisposing factors for poor prognosis of angiosarcoma of the scalp and face: systematic review and meta-analysis.Head Neck. 2017; 39: 380-386
- Prognostic factors in a large nationwide cohort of histologically confirmed primary and secondary angiosarcomas.Cancers (Basel). 2019; 11https://doi.org/10.3390/cancers11111780150
- A multicenter phase II study of Q3 week or weekly paclitaxel in combination with bevacizumab for the treatment of metastatic or unresectable angiosarcoma.Rare Tumors. 2018; 10 (2036361318771771)
- Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face.Cancer. 1999; 86: 2034-2037
- Confirmed activity and tolerability of weekly paclitaxel in the treatment of advanced angiosarcoma.Sarcoma. 2016; 2016: 6862090
- Docetaxel: a therapeutic option in the treatment of cutaneous angiosarcoma: report of 9 patients.Cancer. 2007; 110: 648-651
- Phase II trial of gemcitabine and docetaxel with bevacizumab in soft tissue sarcoma.Sarcoma. 2015; 2015: 532478
- Differences in the efficacies of pazopanib and gemcitabine/docetaxel as second-line treatments for metastatic soft tissue sarcoma.Oncology. 2019; 96: 59-69
- Multicenter phase II trial of pazopanib (P) in patients with angiosarcoma (AS).J Clin Oncol. 2019; 37: 11039
- Kaposi. Idiopathisches multiples Pigmentsarkom der Haut.Archiv für Dermatologie und Syphilis. 1872; 4: 265-273
- Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.Science. 1994; 266: 1865-1869
- Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus.Nature. 1998; 394: 588-592
- Kaposi sarcoma.Nat Rev Dis Primers. 2019; 5: 9
- Classic Kaposi sarcoma: epidemiology and risk factors.Cancer. 2000; 88: 500-517
- The geographical distribution of Kaposi's sarcoma and of lymphomas in Africa before the AIDS epidemic.Br J Cancer. 1998; 78: 1521-1528
- Part I: cancer in indigenous Africans--burden, distribution, and trends.Lancet Oncol. 2008; 9: 683-692
- Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection?.Lancet. 1990; 335: 123-128
- Epidemiology of classic and AIDS-related Kaposi's sarcoma in the USA: incidence, survival, and geographical distribution from 1975 to 2005.Epidemiol Infect. 2013; 141: 200-206
- Kaposi's sarcoma and transplantation.Herpes. 2000; 7: 18-23
- The epidemiology of cancers in human immunodeficiency virus infection and after organ transplantation.Semin Oncol. 2015; 42: 247-257
- A fifth subtype of Kaposi's sarcoma, classic Kaposi's sarcoma in men who have sex with men: a cohort study in Paris.J Eur Acad Dermatol Venereol. 2018; 32: 1377-1384
- Accuracy of clinical suspicion and pathologic diagnosis of Kaposi sarcoma in East Africa.J Acquir Immune Defic Syndr. 2016; 71: 295-301
- Management of Kaposi sarcoma after solid organ transplantation: a European retrospective study.J Am Acad Dermatol. 2019; 81: 448-455
- Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UK.AIDS. 2013; 27: 1603-1613
- Prospective stage-stratified approach to AIDS-related Kaposi's sarcoma.J Clin Oncol. 2014; 32: 409-414
- Diagnosis and treatment of Kaposi's sarcoma: European consensus-based interdisciplinary guideline (EDF/EADO/EORTC).Eur J Cancer. 2019; 114: 117-127
- Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.J Clin Oncol. 1998; 16: 2445-2451
- Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group.J Clin Oncol. 1998; 16: 683-691
- Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma.J Clin Oncol. 1999; 17: 1876-1883
- Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: evidence of symptom palliation from chemotherapy.Cancer. 2010; 116: 3969-3977
- Treatment of advanced AIDS-associated Kaposi sarcoma in resource-limited settings: a three-arm, open-label, randomised, non-inferiority trial.Lancet. 2020; 395: 1195-1207
- Phase II study of bevacizumab in patients with HIV-associated Kaposi's sarcoma receiving antiretroviral therapy.J Clin Oncol. 2012; 30: 1476-1483
- Pomalidomide for symptomatic Kaposi's sarcoma in people with and without hiv infection: a phase I/II study.J Clin Oncol. 2016; 34: 4125-4131
- Phase II trial of imatinib in AIDS-associated Kaposi's sarcoma: AIDS Malignancy Consortium Protocol 042.J Clin Oncol. 2014; 32: 402-408
- Phase II evaluation of low-dose oral etoposide for the treatment of relapsed or progressive AIDS-related Kaposi's sarcoma: an AIDS Clinical Trials Group clinical study.J Clin Oncol. 2002; 20: 3236-3241
- Pilot Trial AMC-063: safety and efficacy of bortezomib in AIDS-associated Kaposi sarcoma.Clin Cancer Res. 2020; 26: 558-565
- Emerging therapies for rare cutaneous cancers: a systematic review.Cancer Treat Rev. 2021; 100: 102266
- Successful treatment of HIV-associated Kaposi sarcoma with immune checkpoint blockade.Cancer Immunol Res. 2018; 6: 1129-1135
- PD-1 blockade with nivolumab in endemic Kaposi sarcoma.Ann Oncol. 2018; 29: 1067-1069
- Assessment of the safety of pembrolizumab in patients with HIV and advanced cancer-a phase 1 study.JAMA Oncol. 2019; 5: 1332-1339
- PD1 blockade with pembrolizumab in classic and endemic Kaposi sarcoma: a multicenter phase II study.Ann Oncol. 2020; 31: S732
- Survival of classic Kaposi's sarcoma and risk of second cancer.Br J Cancer. 1996; 74: 1812-1814
- Systemic treatment initiation in classical and endemic Kaposi's sarcoma: risk factors and global multi-state modelling in a monocentric cohort study.Cancers (Basel). 2021; 13https://doi.org/10.3390/cancers13112519
- AIDS-related Kaposi's sarcoma: prospective validation of the AIDS Clinical Trials Group staging classification. AIDS Clinical Trials Group Oncology Committee.J Clin Oncol. 1997; 15: 3085-3092
- AIDS-related Kaposi's sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS Clinical Trial Group Staging System in the Haart Era--the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive From Antiretrovirals.J Clin Oncol. 2003; 21: 2876-2882
- Kaposi sarcoma incidence and survival among HIV-infected homosexual men after HIV seroconversion.J Natl Cancer Inst. 2010; 102: 784-792
- Kaposi's sarcoma following living donor kidney transplantation: review of 7,939 recipients.Int Urol Nephrol. 2009; 41: 679-685
- Survival after the diagnosis of de novo malignancy in liver transplant recipients.Int J Cancer. 2019; 144: 232-239
Article info
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
